X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC PHARMA with WYETH LTD - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs WYETH LTD - Comparison Results

WYETH LTD 
   Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA WYETH LTD ALEMBIC PHARMA/
WYETH LTD
 
P/E (TTM) x 26.5 27.7 95.8% View Chart
P/BV x 6.1 5.3 113.2% View Chart
Dividend Yield % 0.8 1.3 61.1%  

Financials

 ALEMBIC PHARMA   WYETH LTD
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-16
WYETH LTD
Mar-13
ALEMBIC PHARMA/
WYETH LTD
5-Yr Chart
Click to enlarge
High Rs7921,044 75.8%   
Low Rs443818 54.2%   
Sales per share (Unadj.) Rs167.0298.6 55.9%  
Earnings per share (Unadj.) Rs38.257.2 66.7%  
Cash flow per share (Unadj.) Rs42.058.4 71.9%  
Dividends per share (Unadj.) Rs4.0017.00 23.5%  
Dividend yield (eoy) %0.61.8 35.5%  
Book value per share (Unadj.) Rs84.9249.5 34.0%  
Shares outstanding (eoy) m188.5222.72 829.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.73.1 118.5%   
Avg P/E ratio x16.216.3 99.4%  
P/CF ratio (eoy) x14.715.9 92.2%  
Price / Book Value ratio x7.33.7 194.8%  
Dividend payout %10.529.7 35.3%   
Avg Mkt Cap Rs m116,38321,157 550.1%   
No. of employees `000NA0.5 0.0%   
Total wages/salary Rs m4,214400 1,053.5%   
Avg. sales/employee Rs ThNM13,787.4-  
Avg. wages/employee Rs ThNM813.0-  
Avg. net profit/employee Rs ThNM2,643.3-  
INCOME DATA
Net Sales Rs m31,4876,783 464.2%  
Other income Rs m55353 15.6%   
Total revenues Rs m31,5427,136 442.0%   
Gross profit Rs m10,0601,617 622.0%  
Depreciation Rs m72227 2,714.7%   
Interest Rs m376 669.1%   
Profit before tax Rs m9,3561,938 482.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0-5 0.0%   
Tax Rs m2,160632 341.7%   
Profit after tax Rs m7,1941,301 553.2%  
Gross profit margin %31.923.8 134.0%  
Effective tax rate %23.132.6 70.8%   
Net profit margin %22.819.2 119.2%  
BALANCE SHEET DATA
Current assets Rs m15,0666,984 215.7%   
Current liabilities Rs m7,6742,056 373.3%   
Net working cap to sales %23.572.6 32.3%  
Current ratio x2.03.4 57.8%  
Inventory Days Days6799 67.5%  
Debtors Days Days4124 169.7%  
Net fixed assets Rs m8,237244 3,371.9%   
Share capital Rs m377227 165.9%   
"Free" reserves Rs m15,4165,441 283.3%   
Net worth Rs m16,0055,668 282.4%   
Long term debt Rs m025 0.0%   
Total assets Rs m24,5947,901 311.3%  
Interest coverage x255.2353.3 72.2%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.30.9 149.1%   
Return on assets %29.416.5 177.9%  
Return on equity %44.922.9 195.9%  
Return on capital %58.734.0 172.3%  
Exports to sales %55.70.2 25,547.6%   
Imports to sales %10.436.3 28.7%   
Exports (fob) Rs m17,55115 118,586.5%   
Imports (cif) Rs m3,2832,465 133.2%   
Fx inflow Rs m17,81115 117,174.3%   
Fx outflow Rs m5,3182,677 198.6%   
Net fx Rs m12,493-2,662 -469.3%   
CASH FLOW
From Operations Rs m9,304923 1,007.8%  
From Investments Rs m-3,105317 -979.7%  
From Financial Activity Rs m-1,959-481 407.3%  
Net Cashflow Rs m4,240759 558.6%  

Share Holding

Indian Promoters % 74.1 0.0 -  
Foreign collaborators % 0.0 51.1 -  
Indian inst/Mut Fund % 2.9 11.3 25.7%  
FIIs % 9.1 7.2 126.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 30.4 45.7%  
Shareholders   49,328 21,978 224.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   FULFORD INDIA  VENUS REMEDIES  IPCA LABS  WOCKHARDT LTD.  AUROBINDO PHARMA  

Compare ALEMBIC PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens in Green; Tata Stocks in Focus(09:30 am)

Asian stock indices are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 0.13% while the Hang Seng is down 0.54%. The Shanghai Composite is trading down by 0.02%.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Aug 24, 2017 11:15 AM

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA - ABBOTT INDIA COMPARISON

COMPARE ALEMBIC PHARMA WITH

MARKET STATS